Evidence map›Paper›PMID 22403482›Full record

ArticleBiomarker insights2012

Overcoming the effects of matrix interference in the measurement of urine protein analytes.

Timothy P Taylor, Michael G Janech, Elizabeth H Slate, Evelyn C Lewis, John M Arthur, Jim C Oates

Open access · goldAbstract read
In one paragraph

Article in Biomarker insights, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable UropathogenicFrontiers in cellular and infection microbiology · 2022
    Article
  8. Urinary immunoglobulins in viral diagnosis: An overview.The Indian journal of medical research · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.Arthritis & rheumatology (Hoboken, N.J.) · 2016
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Timothy P TaylorMedical University of South Carolina, Department of Medicine, Division of Nephrology, 96 Jonathan Lucas St., 829 Clinical Science Building, Charleston, SC 29425.
Michael G Janech
Elizabeth H Slate
Evelyn C Lewis
John M Arthur
Jim C Oates
Medical University of South Carolina · USFlorida State University · US

Funding

Patient Resource CoreP60AR062755 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SILVER, RICHARD M. · 2012 to 2016
$5.8M
Prognostic markers in postoperative acute kidney injuryR01DK080234 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ARTHUR, JOHN M. · 2008 to 2011
$1.5M
Urine protein markers of disease in lupus nephritisR21AR051719 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OATES, JAMES C · 2004 to 2005
$126k
CSRD VA I01 CX000218NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R21 AR051719NIDDK NIH HHS R01 DK080234
6 · The paper itself

Abstract

Using multiplex bead assays to measure urine proteins has a great potential for biomarker discovery, but substances in urine (the matrix) can interfere with assay measurements. By comparing the recovery of urine spiked with known quantities of several common analytes, this study demonstrated that the urine matrix variably interfered with the accurate measurement of low abundance proteins. Dilution of the urine permitted a more accurate measure of these proteins, equivalent to the standard dilution technique when the diluted analytes were above the limits of detection of the assay. Therefore, dilution can be used as an effective technique for over-coming urine matrix effects in urine immunoassays. These results may be applicable to other biological fluids in which matrix components interfere with assay performance.

Indexed as

analysis/urineassay validationbiomarkersbody fluids urinestandard addition

Identifiers

PMID22403482
PMCPMC3290108
OpenAlexW1994123721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.